Pharmaco-metabonomic phenotyping and personalized drug treatmentT. Andrew Clayton, Jeremy K. Nicholson, John C. Lindon et al.|Nature|2006Cited by 827
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolismT. Andrew Clayton, Jeremy K. Nicholson, John C. Lindon et al.|Proceedings of the National Academy of Sciences|2009Cited by 764
The therapeutic potential of cannabisDavid Baker, Alan J. Thompson, Gareth Pryce et al.|The Lancet Neurology|2003Cited by 346
Cannabinoids inhibit neurodegeneration in models of multiple sclerosisGareth Pryce, David Baker, Zubair Ahmed et al.|Brain|2003Cited by 341
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple SclerosisDavid Baker, Klaus Schmierer|EBioMedicine|2017Cited by 288